Literature DB >> 22329371

IL28B genetic variants and gender are associated with spontaneous clearance of hepatitis C virus infection.

H-Y Rao1, D-G Sun, D Jiang, R-F Yang, F Guo, J-H Wang, F Liu, H-Y Zhang, H-H Zhang, S-C Du, Q Jin, H Qin, A-S-F Lok, L Wei.   

Abstract

Single nucleotide polymorphisms (SNPs) near the IL28B gene have been shown to be associated with response to treatment for chronic hepatitis C and also with spontaneous clearance of hepatitis C virus (HCV) infection. We analysed the association between IL28B genetic variants and spontaneous clearance of HCV infection in 376 HCV-infected Chinese paid plasma donors. Genotyping of eight SNPs near the IL28B region was performed by the iPLEX system (MassARRAY(®) SNP Genotyping; Sequenom) in all donors, and sequencing was performed on all 80 donors who cleared HCV and on 160 of 296 donors who did not clear HCV to validate the genotypes. Eighty (21.3%) donors spontaneously cleared HCV. Four SNPs were significantly associated with spontaneous HCV clearance: rs8099917 TT (vs GT), rs8105790 TT (vs CT), rs12980275 AA (vs AG) and rs10853728 CC (vs CG or GG) with OR (95% CI) 15.27 (2.07-112.50), 14.88 (2.02-109.72), 7.92 (1.88-33.32) and 2.32 (1.22-4.42) respectively. No association between the other four IL28B SNPs including rs12979860 and spontaneous HCV clearance was found. Women had a higher rate of spontaneous HCV clearance than men [56/213 (26.3%) vs 24/163 (14.6%), P = 0.007], and this was true even after stratification for IL28B genotypes with OR of 1.9-2.2 among those with favourable genotypes. Our results confirmed that IL28B polymorphism is associated with spontaneous clearance of HCV in Chinese subjects, but the SNPs that predict HCV clearance in Chinese subjects were different from those reported in Caucasians. Women were more likely to clear HCV infection regardless of IL28B genotypes.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22329371     DOI: 10.1111/j.1365-2893.2011.01497.x

Source DB:  PubMed          Journal:  J Viral Hepat        ISSN: 1352-0504            Impact factor:   3.728


  33 in total

Review 1.  KASL clinical practice guidelines: management of hepatitis C.

Authors: 
Journal:  Clin Mol Hepatol       Date:  2016-03-28

Review 2.  Germline genetic variants with implications for disease risk and therapeutic outcomes.

Authors:  Amy L Pasternak; Kristen M Ward; Jasmine A Luzum; Vicki L Ellingrod; Daniel L Hertz
Journal:  Physiol Genomics       Date:  2017-09-08       Impact factor: 3.107

3.  A thymine-adenine dinucleotide repeat polymorphism near IL28B is associated with spontaneous clearance of hepatitis C virus.

Authors:  Satoshi Hiramine; Masaya Sugiyama; Norihiro Furusyo; Hirofumi Uto; Akio Ido; Hirohito Tsubouchi; Hisayoshi Watanabe; Yoshiyuki Ueno; Masaaki Korenaga; Kazumoto Murata; Naohiko Masaki; Jun Hayashi; David L Thomas; Masashi Mizokami
Journal:  J Gastroenterol       Date:  2015-03-05       Impact factor: 7.527

4.  Interleukin-28 and hepatitis C virus genotype-4: treatment-induced clearance and liver fibrosis.

Authors:  Moutaz Derbala; Nasser Rizk; Fatima Shebl; Saad Alkaabi; Nazeeh Eldweik; Anil John; Manik Sharma; Rafie Yaqoob; Muneera Almohanadi; Mohammed Butt; Khaled Alejji
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 5.  Acute hepatitis C: management in the rapidly evolving world of HCV.

Authors:  Suraj A Sharma; Jordan J Feld
Journal:  Curr Gastroenterol Rep       Date:  2014-02

Review 6.  Host genetic variants in the pathogenesis of hepatitis C.

Authors:  Monika Rau; Katharina Baur; Andreas Geier
Journal:  Viruses       Date:  2012-12       Impact factor: 5.048

7.  Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients.

Authors:  Sayeh Ezzikouri; Rhimou Alaoui; Khadija Rebbani; Ikram Brahim; Fatima-Zohra Fakhir; Salwa Nadir; Helmut Diepolder; Salim I Khakoo; Mark Thursz; Soumaya Benjelloun
Journal:  PLoS One       Date:  2013-01-24       Impact factor: 3.240

8.  New tools in HCV diagnosis, in light of the enhanced awareness and the new drugs for treatment: SMARTube and stimmunology.

Authors:  Svetlana Gorodin; Serhat Unal; Youchun Wang; Mikhail I Mikhaylov; Ludmila Bigbulatova; Tamar Jehuda-Cohen
Journal:  ScientificWorldJournal       Date:  2013-02-14

9.  Correlation of viral loads with HCV genotypes: higher levels of virus were revealed among blood donors infected with 6a strains.

Authors:  Xia Rong; Ling Lu; Junzhi Wang; Huaping Xiong; Jieting Huang; Jinyan Chen; Ke Huang; Ru Xu; Min Wang; Xuemei Zhang; Tai Guo; Yueyue Liu; Guoquan Gao; Yongshui Fu; Kenrad E Nelson
Journal:  PLoS One       Date:  2012-12-17       Impact factor: 3.240

Review 10.  Dendritic cells, regulatory T cells and the pathogenesis of chronic hepatitis C.

Authors:  Phyllis T Losikoff; Alyssa A Self; Stephen H Gregory
Journal:  Virulence       Date:  2012-10-17       Impact factor: 5.882

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.